SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-20-038303
Filing Date
2020-02-14
Accepted
2020-02-14 16:21:56
Documents
1
Group Members
ATLAS ENHANCED FUND, L.P.ATLAS ENHANCED FUND, LTD.ATLAS ENHANCED MASTER FUND, LTD.ATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL JAPAN UNIT TRUSTATLAS GLOBAL, LLCATLAS INSTITUTIONAL FUND, LLCATLAS INSTITUTIONAL FUND, LTD.ATLAS MASTER FUND, LTD.DMITRY BALYASNY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d855191dsc13ga.htm SC 13G/A 228467
  Complete submission text file 0001193125-20-038303.txt   230533
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 20620323
SIC: 2834 Pharmaceutical Preparations

Mailing Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606
Business Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A